SARS_CoV_2 mutation literature information.


  Insights into the mutation T1117I in the spike and the lineage B.1.1.389 of SARS-CoV-2 circulating in Costa Rica.
 PMID: 35155843       2022       Gene reports
Figure: The B.1.1.389 was the only lineage that carries the S:T1117I as a characteristic mutation (marker for the lineage), unlike the other groups in which this mutation is not widely found among the genomes of the lineage.
Figure: The drug was docked into the HR1 region of S2 domain in the spike, using the WT or the mutated (S:D614G and S:T1117I) proteins.
Figure: The lineage is characterized by the presence of eight mutations including two in the spike, the D614G and the


  Insights into the mutation T1117I in the spike and the lineage B.1.1.389 of SARS-CoV-2 circulating in Costa Rica.
 PMID: 33905892       2021       Infection, genetics and evolution
Conclusion: Interestingly, the variant T1117I in the Spike has increased its frequency along time from March to November 2020.
Conclusion: The Spike variant T1117I must be closely surveyed to see if it will become the predominant circulating variant in our country.
Result: The T1117I and D614G are located in different domains.


  E484K as an innovative phylogenetic event for viral evolution: Genomic analysis of the E484K spike mutation in SARS-CoV-2 lineages from Brazil.
 PMID: 34044192       2021       Infection, genetics and evolution
Introduction: Without previous introductions in other Latin American countries, which have been affected by their own specific mutations, such as the convergent evolution of the S:T1117I in Costa Rica the E484K mutation arose independently in Brazil and was identified in the Rio de Janeiro state (Southeast Brazil) in early-October carried by the P.2 lineage.


  Mutational analysis in international isolates and drug repurposing against SARS-CoV-2 spike protein: molecular docking and simulation approach.
 PMID: 34307771       2021       Virusdisease
Table: T1117I



Browser Board

 Co-occurred Entities




   Filtrator